According to Chang et al., blood levels of β-catenin and WISP-1 were higher in breast cancer patients compared to controls, and they also discovered a significant positive connection between the two proteins in serum samples, also raising the prospect that circulating β-catenin could be employed as a breast cancer biomarker for prognosis and/or diagnosis [33]. Here, CCN4 is linked to breast carcinoma.